Tetra (3-bromo-4-carboxy-5-sulfo)phthalocyanine cobalt
The invention relates to new substituted the phthalocyanine, which may find application as a dye, catalyst different redox processes. Describes Tetra(3-bromo-4-carboxy-5-sulfo)cobalt phthalocyanine of the formula I

















Claims
Tetra (3-bromo-4-carboxy-5-sulfo)phthalocyanine cobalt formulas
Same patents:
The invention relates to methods for producing socialization for the polymerization of butadiene, occurring in the presence of cobalt containing catalysts, and may find application in the IC industry in the production of CIS-1,4-polybutadiene
The invention relates to storage-based catalysts on the media that are used in the polymerization of olefins
The invention relates to an improved dual metallocyanide (DMC) catalysts and methods for their preparation
The invention relates to an improved dual metallocyanide (DMC) catalysts and methods for their preparation
The invention relates to the preparation of catalyst components on the carrier, including a carrier and alumoxane, the catalysts on the media containing the metallocene compound and the ways polyaddition using these catalysts
The invention relates to the synthesis of alternating copolymers of carbon monoxide and olefins under the action of catalysts containing phosphine palladium salt and an organic boron salt
Amplifiers adhesion rubber // 2218344
The invention relates to ORGANOMETALLIC compounds, to compositions containing them and their use
The invention relates to petrochemistry, specifically to the production dialkyldithiocarbamate accelerators of vulcanization of rubbers
Underrattelsetjansten phthalocyanine cobalt // 2210572
The invention relates to a method for the polymerization of 1-olefins which can be used in catalytic systems and which include nitrogen-containing compounds of transition metals, including structural unit represented by the formula (V), where M represents Fe (II), Fe (III), Ru (II), Ru (III) or Ru (IV), X represents an atom of Cl or Br, T denotes the oxidation state of the transition metal M and b is the valency of the group X, the values of each of R1, R2, R3, R4and R6independently from each other selected from hydrogen, methyl, ethyl, n-propyl, n-butyl, n-hexyl, n-octyle, and values of each of R5and R7independently from each other selected from phenyl, 1-naphthyl, 2-naphthyl, 2-methylphenyl, 2-ethylphenyl, 2,6-diisopropylphenyl, 2,3-diisopropylphenyl, 2,4-diisopropylphenyl, 2,6-di-n-butylphenyl, 2,6-dimetilfenil, 2,3-dimetilfenil, 2,4-dimetilfenil, 2-tert-butylphenyl, 2,6-diphenylphenol, 2,4,6-trimetilfenil, 2,6-triptoreline, 4-bromo-2,6-dimetilfenil, 3,5-dichloro-2,6-diethylphenyl and 2,6-bis(2,6-dimetilfenil)phenyl, the cyclohexyl and pyridinyl
The invention relates to a new method of obtaining metallizovannyh derived bacteriochlorophyll for use in the methods of photodynamic therapy (PDT) and in vivo diagnostics and photodynamic destruction of viruses and microorganisms in vitro, as well as some new metallosalen derived bacteriochlorophyll
The invention relates to a new stable complex compound containing macrocyclic tetradentate ligand having the structure of formula I, where R1and R2have the same or different values are related or unrelated, and each is selected from the group consisting of hydrogen, halogen, methyl, CF3and, if they are connected, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, are spatial and confirmation difficult, so that the oxidative degradation of complex metal compound is limited, when the complex is in the presence of an oxidizing environment, Z represents a stable to oxidation atom, which metallocomplexes selected from nitrogen and oxygen, X represents an oxidation resistant functional group selected from O or NRswhere Rsrepresents a methyl, phenyl, hydroxyl, auxillou group, CF3or CH2CF3, R3, R4, R5represent fragments of connecting adjacent Z atoms containing structure described in the claims
- cyclodextrin and method of suppressing tumor growth" target="_blank">
The invention relates to organic chemistry, and medicine, and it applies to substances used in combination with ascorbic acid for the treatment of malignant neoplasms (binary catalytic "dark" therapy of malignant tumors) and method of suppressing tumor growth
The invention relates to new chemical compound, namely, tetrakis-(L-histidine)-
-peroxidizability (III) the heptahydrate formula Co2(His)4O2
7H2O


The invention relates to a phthalocyanine of the formula (I) used as a means for marking liquids, such as mineral oils